Sorrento’s liver artery-infused CAR-T cells showed positive effect in early-stage study – Seeking Alpha
|
Sorrento's liver artery-infused CAR–T cells showed positive effect in early-stage study
Seeking Alpha Results from three heavily pretreated patients with CEA-positive liver metastases in a Phase 1b clinical trial who received Sorrento Therapeutics' (SRNE -1.4%) autologous anti-CEA CAR–T cells via hepatic artery infusion showed a treatment effect … Sorrento (SRNE) Says Anti-CEA CAR-T Cell Therapy for Liver … Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for … |
